Adalimumab/etanerceptCerebral toxoplasmosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1613卷 / 1期

关键词：

D O I：

10.1007/s40278-016-19971-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：13 / 13

相关论文

共 50 条

[21] ImmunosuppresantsSevere toxoplasmosis: case report
Reactions Weekly, 2022, 1921 (1) : 153 - 153
[22] Toxoplasmosis Neuroretinitis: A Case Report
Shoeibi, Nasser
Hosseini, Seyedeh Maryam
Bayani, Razie
IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (04)
[23] MethylprednisoloneCerebral toxoplasmosis: case report
Reactions Weekly, 2016, 1602 (1) : 173 - 173
[24] UstekinumabOcular toxoplasmosis: case report
Reactions Weekly, 2020, 1816 (1) : 309 - 309
[25] AlemtuzumabCerebral toxoplasmosis: case report
Reactions Weekly, 2020, 1787 (1) : 24 - 24
[26] ImmunosuppressantsDisseminated toxoplasmosis: case report
Reactions Weekly, 2018, 1692 (1) : 171 - 171
[27] Adalimumab/etanerceptUnstable diabetes mellitus (first report with adalimumab): case report
Reactions Weekly, 2007, 1134 (1) : 6 - 6
[28] Adalimumab/infliximabLupus: case report
Reactions Weekly, 2009, 1277 (1) : 6 - 6
[29] Adalimumab/etanerceptHistoplasmosis: case report
Reactions Weekly, 2015, 1569 (1) : 17 - 17
[30] Adalimumab/etanerceptDermatomyositis: case report
Reactions Weekly, 2013, 1478 (1) : 5 - 5

← 1 2 3 4 5 →